Sean O'Bryan
Keine laufenden Positionen mehr
Karriereverlauf von Sean O'Bryan
Ehemalige bekannte Positionen von Sean O'Bryan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | General Counsel | 01.11.2020 | 01.01.2022 |
| SIO GENE THERAPIES INC. | Public Communications Contact | 01.12.2018 | 01.11.2020 |
| LYSOGENE | General Counsel | 01.01.2016 | 01.12.2018 |
| BLUEBIRD BIO, INC. | General Counsel | 01.08.2014 | 01.10.2015 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | General Counsel | 01.04.2006 | 01.08.2014 |
| AVROBIO, INC. | General Counsel | 01.02.2022 | - |
Ausbildung von Sean O'Bryan
| Boston University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Frankreich | 2 |
| Israel | 2 |
Operativ
| General Counsel | 5 |
| Undergraduate Degree | 1 |
| Public Communications Contact | 1 |
Sektoral
| Health Technology | 6 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| LYSOGENE | Commercial Services |
| BLUEBIRD BIO, INC. | Health Technology |
| AVROBIO, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Sean O'Bryan
- Erfahrung
